Document Detail

Platelet depletion, platelet activation and coagulation during treatment with hemodialysis.
MedLine Citation:
PMID:  21303224     Owner:  NLM     Status:  Publisher    
Abstract Bioincompatibility is the total of side effects during hemodialysis (HD) including, amongst others, changes in platelet (PLT) level. Deviations in PLT count, immature PLT count, PLT morphology, CD62p expression, Platelet Factor 4 (PF4), ?-Thromboglobulin (?-TG), serotonin, Thrombin-Antithrombin III (TAT) and Prothrombin Fragment 1+2 (F1+2) are monitored before and during treatment with HD in order to elucidate the interaction between modifications in PLT morphology, PLT activation and markers concerning activation of coagulation. Different patterns with time indicate that there is no correlation between an increased amount of depleted PLTs and increased amounts of PLT activation markers such as CD62p, PF4, ?-TG and serotonin. A statistically significant correlation between increased PLT activation markers and markers for increased activation of coagulation such as TAT and F1+2 has not been established. Only a weak correlation is demonstrated between the increase of markers for activation of coagulation and the decrease in PLT counts, immature PLT counts and depleted PLTs during HD treatment. The change in the extracorporeal circuit during HD is probably a more critical factor in the mechanism leading to activation of the coagulation pathway than the modifications in PLT morphology.
Marianne Schoorl; Margreet Schoorl; Menso J Nub; Piet C M Bartels
Related Documents :
21364954 - Plasmin inhibitors prevent leukocyte accumulation and remodeling events in the postisch...
3990524 - Inhibition of c28 and c29 phytosterol metabolism by n,n-dimethyldodecanamine in the nem...
21360514 - Low-dose naproxen interferes with the antiplatelet effects of aspirin in healthy subjec...
18005844 - Effects of different debonding techniques on the debonding forces and failure modes of ...
7712124 - Design of orally active, non-peptide fibrinogen receptor antagonists. an evolutionary p...
16916914 - In vivo effects of lipopolysaccharide and tlr4 on platelet production and activity: imp...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-2-8
Journal Detail:
Title:  Scandinavian journal of clinical and laboratory investigation     Volume:  -     ISSN:  1502-7686     ISO Abbreviation:  -     Publication Date:  2011 Feb 
Date Detail:
Created Date:  2011-2-9     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0404375     Medline TA:  Scand J Clin Lab Invest     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Department of Clinical Chemistry, Hematology & Immunology, Medical Center Alkmaar, The Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Plasma netrin-1 is a diagnostic biomarker of human cancers.
Next Document:  Cholinesterase modulations in patients with acute bacterial meningitis.